Skip to content

Dermatological safety Study of Cosmetics on healthy human volunteers

Evaluation of dermatological safety and hypo allergenicity of investigational products by Human Repeat Insult Patch Test HRIPT on healthy human volunteers as per IS 4011:2018 - HRIPT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056655
Enrollment
50
Registered
2023-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Farmherbs Herbal Baby Oil: 40 µl of investigational product (without dilution) was applied on the precut filter paper placed inside the allotted Derma proof Aluminium Finn chamber prefi

Sponsors

Sreedhareeyam Farmherbs India P Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Voluntary men/women between 18 and 65 years. • Photo type III to V. • Self-declaration of subject with sensitive skin. • Having apparently healthy skin on test area. • For whom the investigator considers that the compliance will be correct. • Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures. • Having signed a Consent Form. • Willingness to avoid intense UV exposure on test site (sun or artificial UV), during the course of the study. • Willingness to avoid excessive water contact (for example swimming) or activity which causes excessive sweating (that is exercise, sauna…), during the course of the study. • Should be able to read and write (in English, Hindi or local language). • Having valid proof of identity and age.

Exclusion criteria

Exclusion criteria: • Pregnant/nursing mothers • Scars, excessive terminal hair or tattoo on the studied area. • Henna tattoo anywhere on the body (in case of studies involving hair dyes). • Dermatological infection/pathology on the level of studied area. • Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye). • Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures. • Chronic illness which may influence the outcome of the study. • Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month). • Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.

Design outcomes

Primary

MeasureTime frame
1. To determine the irritation & or sensitization potential of a test material. 2. In support of sensitive skin claims & supporting evidence for hypo allergenicity claims after repeated application under occlusive or semi occlusive patches to the skin of human subjects.Timepoint: Day 1 to Day 40

Secondary

MeasureTime frame
Incidence & rate of adverse events.Timepoint: Day 1 to Day 40

Countries

India

Contacts

Public ContactDr Ashok Godavarthi

Radiant Research Services Pvt. Ltd

surya.ashok@gmail.com9880999297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026